baylor-logo-wire-500x500.jpg
Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024
23 janv. 2024 09h00 HE | Baylor Genetics
Showcase Presentation to Include Case Examples from NIH’s Undiagnosed Diseases Network (UDN)
Newborn Metabolic Screening Market Size is Projected to Grow from US$ 295.7 Million in 2022 to US$ 757.9 Million by 2032, Exhibiting a CAGR of 8.9% | Persistence Market Research
22 janv. 2024 03h15 HE | Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newborn Metabolic Screening Market Overview: The Newborn Metabolic Screening Market is a crucial component of newborn healthcare, aimed at detecting...
baylor-logo-wire-500x500.jpg
Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and Partners
03 janv. 2024 10h00 HE | Baylor Genetics
Company Expands Test Offerings, Lab Technology, and Customer-Centric Tools Rapid Comprehensive Whole Genome and Exome Sequencing, Disease-Specific Panels and Customizable Solutions Advance Diagnoses...
Webinar Host
Understanding Resilience to Schizophrenia through Genetics - A Free Webinar from the Brain & Behavior Research Foundation
05 déc. 2023 10h45 HE | Brain & Behavior Research Foundation
New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Understanding Resilience to Schizophrenia through Genetics” on Tuesday,...
AMR Logo.png
RNA Based Therapeutics Market Is Projected to Gain $25,121.95 Million by 2030: Allied Market Research
15 nov. 2023 10h42 HE | Allied Market Research
Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “RNA Based Therapeutics Market by Disease Type (RNA antisense and RNA interference (RNAi)),...
baylor-logo-wire-500x500.jpg
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences
02 oct. 2023 10h00 HE | Baylor Genetics
Baylor Genetics to present at three top genetic conferences on WES, WGS, carrier screening and non-invasive prenatal testing
baylor-logo-wire-500x500.jpg
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
12 sept. 2023 08h00 HE | Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
new_logo.png
Carrier Screening Market to accrue USD 6 billion by 2032, Says Graphical Research Powered by GMI
11 juin 2023 21h00 HE | Graphical Research
Selbyville, Delaware, June 11, 2023 (GLOBE NEWSWIRE) -- Carrier Screening Market size is slated to reach USD 6 billion by 2032. Growing demand for personalized medicine will act as a major factor...
MicrosoftTeams-image (5).png
Viral Vector Production Market to Reach USD 17.3 Bn by 2031, growing at a CAGR of 4.4%: as per TMR Study
09 mai 2023 08h30 HE | Transparency Market Research
Wilmington, Delaware, United States, May 09, 2023 (GLOBE NEWSWIRE) -- The global viral vector production market stood at USD 16.7 Bn in 2022 and is anticipated to exceed USD 17.3 Bn by 2031,...
TIP_link_300x300.jpg
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
28 févr. 2023 08h28 HE | The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...